Literature DB >> 18590693

Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation.

Xiaocheng C Dong1, Kyle D Copps, Shaodong Guo, Yedan Li, Ramya Kollipara, Ronald A DePinho, Morris F White.   

Abstract

The forkhead transcription factor Foxo1 regulates expression of genes involved in stress resistance and metabolism. To assess the contribution of Foxo1 to metabolic dysregulation during hepatic insulin resistance, we disrupted Foxo1 expression in the liver of mice lacking hepatic Irs1 and Irs2 (DKO mice). DKO mice were small and developed diabetes; analysis of the DKO-liver transcriptome identified perturbed expression of growth and metabolic genes, including increased Ppargc1a and Igfbp1, and decreased glucokinase, Srebp1c, Ghr, and Igf1. Liver-specific deletion of Foxo1 in DKO mice resulted in significant normalization of the DKO-liver transcriptome and partial restoration of the response to fasting and feeding, near normal blood glucose and insulin concentrations, and normalization of body size. These results demonstrate that constitutively active Foxo1 significantly contributes to hyperglycemia during severe hepatic insulin resistance, and that the Irs1/2 --> PI3K --> Akt --> Foxo1 branch of insulin signaling is largely responsible for hepatic insulin-regulated glucose homeostasis and somatic growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18590693      PMCID: PMC2929667          DOI: 10.1016/j.cmet.2008.06.006

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  50 in total

1.  High-resolution dynamics of the transcriptional response to nutrition in Drosophila: a key role for dFOXO.

Authors:  Boris Gershman; Oscar Puig; Lilian Hang; Robert M Peitzsch; Marc Tatar; Robert S Garofalo
Journal:  Physiol Genomics       Date:  2006-11-07       Impact factor: 3.107

2.  Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth.

Authors:  Xiaocheng Dong; Sunmin Park; Xueying Lin; Kyle Copps; Xianjin Yi; Morris F White
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

3.  FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.

Authors:  Ji-Hye Paik; Ramya Kollipara; Gerald Chu; Hongkai Ji; Yonghong Xiao; Zhihu Ding; Lili Miao; Zuzana Tothova; James W Horner; Daniel R Carrasco; Shan Jiang; D Gary Gilliland; Lynda Chin; Wing H Wong; Diego H Castrillon; Ronald A DePinho
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

4.  Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection.

Authors:  Marcia M Schilling; James K Oeser; Jared N Boustead; Brian P Flemming; Richard M O'Brien
Journal:  Nature       Date:  2006-10-05       Impact factor: 49.962

5.  Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.

Authors:  David A Guertin; Deanna M Stevens; Carson C Thoreen; Aurora A Burds; Nada Y Kalaany; Jason Moffat; Michael Brown; Kevin J Fitzgerald; David M Sabatini
Journal:  Dev Cell       Date:  2006-12       Impact factor: 12.270

Review 6.  Transcriptional regulation by insulin: from the receptor to the gene.

Authors:  Catherine Mounier; Barry I Posner
Journal:  Can J Physiol Pharmacol       Date:  2006-07       Impact factor: 2.273

7.  SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.

Authors:  Estela Jacinto; Valeria Facchinetti; Dou Liu; Nelyn Soto; Shiniu Wei; Sung Yun Jung; Qiaojia Huang; Jun Qin; Bing Su
Journal:  Cell       Date:  2006-09-07       Impact factor: 41.582

8.  Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism.

Authors:  Michihiro Matsumoto; Seongah Han; Tadahiro Kitamura; Domenico Accili
Journal:  J Clin Invest       Date:  2006-08-10       Impact factor: 14.808

9.  Restoration of glucokinase expression in the liver normalizes postprandial glucose disposal in mice with hepatic deficiency of PDK1.

Authors:  Yasuo Okamoto; Wataru Ogawa; Akihiko Nishizawa; Hiroshi Inoue; Kiyoshi Teshigawara; Shinichi Kinoshita; Yasushi Matsuki; Eijiro Watanabe; Ryuji Hiramatsu; Hiroshi Sakaue; Tetsuo Noda; Masato Kasuga
Journal:  Diabetes       Date:  2007-01-31       Impact factor: 9.461

10.  FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.

Authors:  Wenwei Zhang; Sandip Patil; Balwant Chauhan; Shaodong Guo; David R Powell; Jamie Le; Angelos Klotsas; Ryan Matika; Xiangshan Xiao; Roberta Franks; Kim A Heidenreich; Mini P Sajan; Robert V Farese; Donna Beer Stolz; Patrick Tso; Seung-Hoi Koo; Marc Montminy; Terry G Unterman
Journal:  J Biol Chem       Date:  2006-02-21       Impact factor: 5.157

View more
  198 in total

1.  Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21.

Authors:  Holly A Cyphert; Xuemei Ge; Alison B Kohan; Lisa M Salati; Yanqiao Zhang; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

2.  Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.

Authors:  Kebin Zhang; Ling Li; Yajuan Qi; Xiaoping Zhu; Boyi Gan; Ronald A DePinho; Travis Averitt; Shaodong Guo
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

3.  FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis.

Authors:  Kyoichiro Tsuchiya; Jun Tanaka; Yu Shuiqing; Carrie L Welch; Ronald A DePinho; Ira Tabas; Alan R Tall; Ira J Goldberg; Domenico Accili
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

4.  Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c.

Authors:  Min Wan; Karla F Leavens; Danish Saleh; Rachael M Easton; David A Guertin; Timothy R Peterson; Klaus H Kaestner; David M Sabatini; Morris J Birnbaum
Journal:  Cell Metab       Date:  2011-10-05       Impact factor: 27.287

5.  FoxOs function synergistically to promote glucose production.

Authors:  Rebecca A Haeusler; Klaus H Kaestner; Domenico Accili
Journal:  J Biol Chem       Date:  2010-09-29       Impact factor: 5.157

6.  FOXO transcription factors in non-alcoholic fatty liver disease.

Authors:  X Charlie Dong
Journal:  Liver Res       Date:  2017-09

Review 7.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

8.  Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2(+/Akita):apoE(-/-) mice.

Authors:  John Y Jun; Zhexi Ma; Rajkumar Pyla; Lakshman Segar
Journal:  Atherosclerosis       Date:  2012-10-12       Impact factor: 5.162

9.  Insulin receptor substrate 2-mediated phosphatidylinositol 3-kinase signaling selectively inhibits glycogen synthase kinase 3β to regulate aerobic glycolysis.

Authors:  Justine Landis; Leslie M Shaw
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

10.  Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function.

Authors:  Youcai Deng; Yann Kerdiles; Jianhong Chu; Shunzong Yuan; Youwei Wang; Xilin Chen; Hsiaoyin Mao; Lingling Zhang; Jianying Zhang; Tiffany Hughes; Yafei Deng; Qi Zhang; Fangjie Wang; Xianghong Zou; Chang-Gong Liu; Aharon G Freud; Xiaohui Li; Michael A Caligiuri; Eric Vivier; Jianhua Yu
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.